Human Cytokine-Induced Killer Cells Specifically Infiltrated and Retarded the Growth of the Inoculated Human Cholangiocarcinoma Cells in SCID Mice

REFERENCES

• Watanapa P., Watanapa W. B. Liver fluke-associated cholangiocarcinoma. Br J Surg 2002; 89(8)962–970
   PubMed Web of Science ®Google Scholar
• Jarnagin W. R., Shoup M. Surgical management of cholangiocarcinoma. Semin Liver Dis 2004; 24(2)189–199
   PubMed Web of Science ®Google Scholar
• Wongkajornsilp A., Sangsuriyong S., Hongeng S., Waikakul S., Asavamongkolkul A., Huabprasert S. Effective osteosarcoma cytolysis using cytokine-induced killer cells pre-inoculated with tumor RNA-pulsed dendritic cells. J Ortho Res 2005; 23(6)1460–1466
   PubMed Web of Science ®Google Scholar
• Schmidt-Wolf I. G., Lefterova P., Mehta B. A., Fernandez L. P., Huhn D., Blume K. G., Weissman I. L., Negrin R. S. Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells. Exp Hematol 1993; 21(13)1673–1679
   PubMed Web of Science ®Google Scholar
• Mehta B. A., Schmidt-Wolf I. G., Weissman I. L., Negrin R. S. Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+ CD56+ killer cells. Blood 1995; 86(9)3493–3499
   PubMed Web of Science ®Google Scholar
• Linn Y. C., Hui K. M. Cytokine-induced killer cells: NK-like T cells with cytotolytic specificity against leukemia. Leuk Lymphoma 2003; 44(9)1457–1462
   PubMed Web of Science ®Google Scholar
• Marten A., Renoth S., von Lilienfeld-Toal M., Buttgereit P., Schakowski F., Glasmacher A., Sauerbruch T., Schmidt-Wolf I. G. Enhanced lytic activity of cytokine-induced killer cells against multiple myeloma cells after co-culture with idiotype-pulsed dendritic cells. Haematologica 2001; 86(10)1029–1037
   PubMedGoogle Scholar
• Gonzalez-Carmona M. A., Marten A., Hoffmann P., Schneider C., Sievers E., Schmidt-Wolf I. G., Sauerbruch T., Caselmann W. H. Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells. Liver Int 2006; 26(3)369–379
   PubMed Web of Science ®Google Scholar
• Shi M., Zhang B., Tang Z. R., Lei Z. Y., Wang H. F., Feng Y. Y., Fan Z. P., Xu D. P., Wang F. S. Autologous cytokine-induced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinoma. World J Gastroenterol 2004; 10(8)1146–1151
   PubMed Web of Science ®Google Scholar
• Parajuli P., Mathupala S., Sloan A. E. Systematic comparison of dendritic cell-based immunotherapeutic strategies for malignant gliomas:In vitro induction of cytolytic and natural killer-like T cells. Neurosurgery 2004; 55(5)1194–1204
   PubMed Web of Science ®Google Scholar
• Vichchatorn P., Wongkajornsilp A., Petvises S., Tangpradabkul S., Pakakasama S., Hongeng S. Dendritic cells pulsed with total tumor RNA for activation NK-like T cells against glioblastoma multiforme. J Neurooncol 2005; 75(2)111–118
   PubMed Web of Science ®Google Scholar
• Ziske C., Marten A., Schottker B., Buttgereit P., Schakowski F., Gorschluter M., von Rucker A., Scheffold C., Chao N., Sauerbruch T., Schmidt-Wolf I. G. Resistance of pancreatic carcinoma cells is reversed by coculturing NK-like T cells with dendritic cells pulsed with tumor-derived RNA and CA 19-9. Mol Ther 2001; 3(1)54–60
   PubMed Web of Science ®Google Scholar
• Schmidt J., Eisold S., Buchler M. W., Marten A. Dendritic cells reduce number and function of CD4+CD25+ cells in cytokine-induced killer cells derived from patients with pancreatic carcinoma. Cancer Immunol Immunother 2004; 53(11)1018–1026
   PubMed Web of Science ®Google Scholar
• Sievers E., Albers P., Schmidt-Wolf I. G., Marten A. Telomerase pulsed dendritic cells for immunotherapy for renal cell carcinoma. J Urol 2004; 171(1)114–119
   PubMed Web of Science ®Google Scholar
• Erhardt M., Schmidt-Wolf I. G., Sievers E., Frank S., Strehl J., von Lilienfeld-Toal M., Gorschluter M. Anti-tumoral capabilities of effector cells after IFN-alpha or CpG-motif treatment of cocultured dendritic cells. Arch Immunol Ther Exp (Warsz) 2006; 54(6)403–409
   PubMed Web of Science ®Google Scholar
• Zhang S., Wang Q., Li W. F., Wang H. Y., Zhang H. J. Enhanced antitumor immunity by murine cytokine activated T lymphocytes after cocultured with bone marrow derived dendritic cells pulsed with whole tumor lysates. Leuk Res 2004; 28(10)1085–1088
   PubMed Web of Science ®Google Scholar
• Jiang J., Xu N., Wu C., Deng H., Lu M., Li M., Xu B., Wu J., Wang R., Xu J., Nilsson-Ehle P. Treatment of advanced gastric cancer by chemotherapy combined with autologous cytokine-induced killer cells. Anticancer Res 2006; 26(3B)2237–2242
   PubMed Web of Science ®Google Scholar
• Leemhuis T., Wells S., Scheffold C., Edinger M., Negrin R. S. A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma. Biol Blood Marrow Transplant 2005; 11(3)181–187
   PubMed Web of Science ®Google Scholar
• Neri S., Mariani E., Meneghetti A., Cattini L., Facchini A. Calcein-acetyoxymethyl cytotoxicity assay: standardization of a method allowing additional analyses on recovered effector cells and supernatants. Clin Diagn Lab Immunol 2001; 8(6)1131–1135
   PubMedGoogle Scholar
• Wang H. Y., Wang R. F. Regulatory T cells and cancer. Curr Opin Immunol 2007; 19(2)217–223
   PubMed Web of Science ®Google Scholar
• Mahnke K., Ring S., Johnson T. S., Schallenberg S., Schonfeld K., Storn V., Bedke T., Enk A. H. Induction of immunosuppressive functions of dendritic cells in vivo by CD4+CD25+ regulatory T cells: role of B7-H3 expression and antigen presentation. Eur J Immunol 2007; 37(8)2117–2126
   PubMed Web of Science ®Google Scholar
• Li H., Yu J. P., Cao S., Wei F., Zhang P., An X. M., Huang Z. T., Ren X. B. CD4 +CD25 + regulatory T cells decreased the antitumor activity of cytokine-induced killer (CIK) cells of lung cancer patients. J Clin Immunol 2007; 27(3)317–326
   PubMed Web of Science ®Google Scholar
• Introna M., Borleri G., Conti E., Franceschetti M., Barbui A. M., Broady R., Dander E., Gaipa G., D'Amico G., Biagi E., Parma M., Pogliani E. M., Spinelli O., Baronciani D., Grassi A., Golay J., Barbui T., Biondi A., Rambaldi A. Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I study. Haematologica 2007; 92(7)952–959
   PubMed Web of Science ®Google Scholar